CPBIO Holding Company Limited

CAIHF · Other OTC · USD

1,0677USD

0,00 (0,00 %)Stand 9. Nov., 21:00

Vortag 1,0677

Kennzahlen

Eröffnung
0,28
Vortag
1,0677
Tagesspanne
0,0015 – 1,0677
52 Wochen
0,0015 – 1,07
Volumen
10
Ø Volumen
8
Börsenwert
270,48 Mio. $
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
4,1
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

CPBIO Holding Company Limited is a global entity primarily involved in the production and distribution of chlortetracycline (CTC) and its associated derivatives. The company's business activities span Mainland China, the Asia Pacific region, the Americas, Europe, and other international markets, and are organized into two principal divisions: Biochemical and Industrial. The Biochemical segment concentrates on the formulation and commercialization of CTC premix and CTC hydrochloride products. These substances function as crucial feed additives for livestock, designed to foster growth, ward off or alleviate animal ailments, and enhance feed efficiency, marketed under the "Shihao" and "Citifac" brand names. In contrast, the Industrial segment encompasses the sale, rental, and maintenance services for various Caterpillar heavy equipment, including excavators, power generators, bulldozers, and compactors, alongside their corresponding spare parts. This division also undertakes the manufacturing and supply of carburetors and diverse automotive components for vehicle and motorcycle producers. Established in 1987, the company is headquartered in Central, Hong Kong. Formerly known as Chia Tai Enterprises International Limited, it adopted its current name in July 2026 and operates as a subsidiary of Charoen Pokphand Foods Public Company Limited.

CEO
Chawalit Na Muangtoun
Mitarbeitende
900
Hauptsitz
Hong Kong, HK
Sektor
Healthcare
Branche
Drug Manufacturers - Specialty & Generic
Börsengang
22. Aug. 2023
Website
cp-bio.com

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.